How Will The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Expand At A CAGR Of 8.8% Through 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
In recent times, the ribose-nucleic acid (rna)-based therapeutics market has seen impressive expansion. Its size is predicted to rise from $15.79 billion in 2024 to $17.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this growth in the historic period include increased investment and funding, the discovery of RNA interference (RNAi), successful trials of antisense oligonucleotides (ASOs), supportive regulatory mechanisms and frameworks, as well as alliances and partnerships.
The market for therapeutics based on ribose-nucleic acid (rna) is projected to witness significant expansion in the upcoming years, growing to an evaluation of $24.11 billion by 2029, with a compound annual growth rate (CAGR) of 8.8%. This anticipated growth during the forecast period can be linked to several factors such as a broadening of indications, increased market demand and acceptance, regulatory backing, AI and machine learning integration, and novel applications in the treatment of rare ailments. Key trends for the forecast period comprise progressive delivery systems, RNA therapeutics targeting multiple issues, personalized RNA treatments, advancements in regulation, and growth and commercialisation in the market.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp
What Drivers Are Accelerating Expansion Of The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The escalating frequency of cancer is predicted to boost the expansion of the ribose-nucleic acid (RNA)-based therapeutics market in the future. The term cancer encompasses a situation encompassing abnormal cells that proliferate and spread inexorably, possibly causing death if not treated. Cancer’s prevalence can be attributed to an aging populace, changes in lifestyle, increased exposure to hazards, and improved methods of detection. By specifically tackling the genomic and molecular mechanisms of cancer, RNA-based therapeutics present a hopeful path for cancer treatment. To exemplify, the Australian Institute of Health and Welfare revealed in August 2023 that around 151,000 individuals were diagnosed with cancer (excluding basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) of the skin) in 2021 in Australia. This number is projected to escalate to 185,000 by 2030. Consequently, the escalating frequency of cancer is spurring the growth of the ribose-nucleic acid-based therapeutics market.
What Are The Primary Segmentation Parameters In The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The ribose-nucleic acid (rna)-based therapeuticsmarket covered in this report is segmented –
1) By Type: RNA Interference (RNAi); RNA Antisense
2) By Technology: Enabling Technology; Enabled Technology
3) By Therapeutic Area: Oncology; Genetic Disorder; Ophthalmology; Hematological Disorders; Acute Hepatic Porphyria (AHP); Other Therapeutic Areas
4) By End User: Research Institutes; Hospitals And Clinics
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA); MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs); Antisense RNA
How Are Industry Trends Steering The Expansion Of The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
Prominent entities within the Ribose Nucleic Acid (RNA)-based therapeutic market are concentrating their efforts on concocting progressive medical solutions, such as Messenger RNA (mRNA)-based booster immunizations, with the goal of improving the potency of vaccinations, addressing new variations of viruses, and enhancing the overall longevity of vaccine-induced immunity. An mRNA-based booster vaccination utilizes messenger RNA to trigger cells into producing a protein that bolsters the body’s immunological reaction to specific pathogens. For illustration, in June 2023, Gennova Biopharmaceuticals Ltd – an Indian pharmaceutical firm – released GEMCOVAC-OM, the first mRNA booster immunization in India, designed purposefully for the Omicron variant of COVID-19. This booster became essential due to the limited effectiveness of prior vaccinations against Omicron. Employing mRNA technology, GEMCOVAC-OM amplifies immunity and provides heightened protection against the mutating virus.
Which Players Are Shaping The Competitive Landscape Of The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
Major companies operating in the ribose-nucleic acid (RNA)-based therapeutics market are F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics
Access The Complete Report Here:
What Are The Emerging Regional Trends Driving The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2024. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=18454&type=smp
Browse Through More Reports Similar to the Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market 2025, By The Business Research Company
Isothermal Nucleic Acid Amplification Technology Global Market Report 2025
Nucleic Acid Based Gene Therapy Global Market Report 2025
Nucleic Acid Isolation And Purification Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
